These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32619958)

  • 21. Roflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis.
    Wang Z; Zhang Y; Chai J; Wu Y; Zhang W; Zhang Z
    J Affect Disord; 2024 Apr; 350():761-773. PubMed ID: 38220100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tadalafil (PDE5 inhibitor) and roflumilast (PDE4 inhibitor) on airway reactivity and markers of inflammation in ovalbumin-induced airway hyperresponsiveness in guinea pigs.
    Mokry J; Urbanova A; Medvedova I; Kertys M; Mikolka P; Kosutova P; Mokra D
    J Physiol Pharmacol; 2017 Oct; 68(5):721-730. PubMed ID: 29375047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sumatriptan improves the locomotor activity and neuropathic pain by modulating neuroinflammation in rat model of spinal cord injury.
    Afshari K; Dehdashtian A; Haddad NS; Jazaeri SZ; Ursu DC; Khalilzadeh M; Haj-Mirzaian A; Shakiba S; Burns TC; Tavangar SM; Ghasemi M; Dehpour AR
    Neurol Res; 2021 Jan; 43(1):29-39. PubMed ID: 32935647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
    Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
    J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Effects of Minocycline Pretreatment in the Locomotor and Sensory Complications of Spinal Cord Injury in an Animal Model.
    Afshary K; Chamanara M; Talari B; Rezaei P; Nassireslami E
    J Mol Neurosci; 2020 Jul; 70(7):1064-1072. PubMed ID: 32144723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo.
    Timmer W; Leclerc V; Birraux G; Neuhäuser M; Hatzelmann A; Bethke T; Wurst W
    J Clin Pharmacol; 2002 Mar; 42(3):297-303. PubMed ID: 11865966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose dependent effects of tadalafil and roflumilast on ovalbumin-induced airway hyperresponsiveness in guinea pigs.
    Urbanova A; Medvedova I; Kertys M; Mikolka P; Kosutova P; Mokra D; Mokrý J
    Exp Lung Res; 2017; 43(9-10):407-416. PubMed ID: 29220595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roflumilast: A potential drug for the treatment of cognitive impairment?
    Sugin LJS; Murugesan A; Bindu M; Sunil KN
    Neurosci Lett; 2020 Sep; 736():135281. PubMed ID: 32735939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meglumine cyclic adenylate improves neurological function following acute spinal cord injury in rats.
    Liao J; Xie J; Lin D; Lu N; Guo L; Li W; Pu B; Yang Y; Yang Z; Zhang Y; Song Y
    Mol Med Rep; 2014 Sep; 10(3):1225-30. PubMed ID: 24970286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-21 inhibitor improves locomotor function recovery by inhibiting IL-6R/JAK-STAT pathway-mediated inflammation after spinal cord injury in model of rat.
    Ning SL; Zhu H; Shao J; Liu YC; Lan J; Miao J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):433-440. PubMed ID: 30720148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Considerations for Roflumilast: A New Treatment for COPD.
    Kelly Freeman ML
    Consult Pharm; 2012 Mar; 27(3):189-93. PubMed ID: 22421519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-92b-5p inhibitor suppresses IL-18 mediated inflammatory amplification after spinal cord injury via IL-18BP up-regulation.
    Lin XL; Zhu J; Wang LM; Yan F; Sha WP; Yang HL
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1891-1898. PubMed ID: 30915731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone Deacetylase 3 Inhibition Ameliorates Microglia-Mediated Neuro-Inflammation Via the SIRT1/Nrf2 Pathway After Traumatic Spinal Cord Injury.
    Chen S; Ye J; Wu G; Shi J; Li X; Chen X; Wu W
    Neurorehabil Neural Repair; 2023 Aug; 37(8):503-518. PubMed ID: 37503724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions.
    van Schalkwyk E; Strydom K; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbröker D; Bardin PG
    J Allergy Clin Immunol; 2005 Aug; 116(2):292-8. PubMed ID: 16083782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective Effect of Mild Hypothermia on Spinal Cord Ischemia-Induced Delayed Paralysis and Spinal Cord Injury.
    Fu D; Chen C; He L; Li J; Li A
    Neurochem Res; 2022 May; 47(5):1212-1225. PubMed ID: 34993705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterase-4 inhibition restored hippocampal long term potentiation after primary blast.
    Vogel EW; Morales FN; Meaney DF; Bass CR; Morrison B
    Exp Neurol; 2017 Jul; 293():91-100. PubMed ID: 28366471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of lung inflammation, oxidative stress and apoptosis by the PDE4 inhibitor roflumilast in experimental model of acute lung injury.
    Kosutova P; Mikolka P; Kolomaznik M; Balentova S; Adamkov M; Calkovska A; Mokra D
    Physiol Res; 2018 Dec; 67(Suppl 4):S645-S654. PubMed ID: 30607971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines.
    Ghosh M; Xu Y; Pearse DD
    J Neuroinflammation; 2016 Jan; 13():9. PubMed ID: 26757726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roflumilast Reduces Cerebral Inflammation in a Rat Model of Experimental Subarachnoid Hemorrhage.
    Wu Q; Qi L; Li H; Mao L; Yang M; Xie R; Yang X; Wang J; Zhang Z; Kong J; Sun B
    Inflammation; 2017 Aug; 40(4):1245-1253. PubMed ID: 28451841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the role of roflumilast in chronic obstructive pulmonary disease?
    Lau C; Mehta AC; Hatipoglu U
    Cleve Clin J Med; 2017 Jan; 84(1):13-15. PubMed ID: 28084977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.